DCF — ASPIRUS STEVENS POINT HOSPITAL
Enterprise Value: $128.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$128.4M
Enterprise Value
$32.7M
PV of Cash Flows
$95.7M
PV of Terminal Value
$154.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $207.5M | $17.6M | 9.0% | $5.7M | $5.2M |
| Year 2 | $213.7M | $20.3M | 10.0% | $7.5M | $6.2M |
| Year 3 | $220.1M | $23.1M | 11.0% | $9.4M | $7.1M |
| Year 4 | $226.7M | $24.9M | 11.0% | $10.5M | $7.2M |
| Year 5 | $233.5M | $26.3M | 11.0% | $11.3M | $7.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $128.4M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$201.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000119152899
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5